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In vitro gene regulatory networks predict in vivo
function of liver
Youping Deng1*, David R Johnson2, Xin Guan3, Choo Y Ang3, Junmei Ai4, Edward J Perkins2
Abstract
Background: Evolution of toxicity testing is predicated upon using in vitro cell based systems to rapidly screen
and predict how a chemical might cause toxicity to an organ in vivo. However, the degree to which we can
extend in vitro results to in vivo activity and possible mechanisms of action remains to be fully addressed.
Results: Here we use the nitroaromatic 2,4,6-trinitrotoluene (TNT) as a model chemical to compare and determine
how we might extrapolate from in vitro data to in vivo effects. We found 341 transcripts differentially expressed in
common among in vitro and in vivo assays in response to TNT. The major functional term corresponding to these
transcripts was cell cycle. Similarly modulated common pathways were identified between in vitro and in vivo.
Furthermore, we uncovered the conserved common transcriptional gene regulatory networks between in vitro and
in vivo cellular liver systems that responded to TNT exposure, which mainly contain 2 subnetwork modules: PTTG1
and PIR centered networks. Interestingly, all 7 genes in the PTTG1 module were involved in cell cycle and
downregulated by TNT both in vitro and in vivo.
Conclusions: The results of our investigation of TNT effects on gene expression in liver suggest that gene
regulatory networks obtained from an in vitro system can predict in vivo function and mechanisms. Inhibiting
PTTG1 and its targeted cell cyle related genes could be key machanism for TNT induced liver toxicity.
Background
High-throughput toxicity testing is predicated upon
using in vitro cell based systems to rapidly screen and
predict how a chemical might cause toxicity to an organ
in vivo [1]. Recent microarray studies have shown that
the in vitro gene expression profiles in liver slices trea-
ted with various compounds could predict the toxicity
and pathology observed in vivo [2]. However, the degree
to which in vitro results can be extended to in vivo
activity and possible mechanisms of action remains to
be fully addressed.
Compared with animal models, primary cell cultures
have advantages for investigating mechanisms of chemi-
cal toxicity. Primary cultured cells, such as hepatocytes,
can offer a convenient system that is easily genetically
manipulated and can be used to test various throughput
screens using different molecular and biochemical meth-
ods. Use of primary cell cultures can also reduce cost
and mitigate animal welfare concerns inherent in in vivo
studies [3]. In vitro systems have a long history of use in
screening new drugs for human diseases such as cancer
and in studying cellular and molecular events of differ-
ent molecules (e.g., pharmaceuticals and xenobiotics)
[4,5].
In this study, we used the nitroaromatic 2,4,6 -rinitro-
toluene (TNT) as a model chemical to compare and
determine how we might extrapolate in vitro data to in
vivo systems. We compared the gene expression profiles
of in vitro primary liver cells with the gene expression
profiles of in vivo liver tissue of rats exposed to TNT.
TNT is a munitions compound which is released to
the environment as a result of military training activities
and manufacturing processes [6,7]. The major toxic
effects to rats in response to TNT exposure are methe-
moglobinemia, anemia, hypercholesterolemia, and hepa-
tomegaly, splenomegaly, and testicular atrophy with
their accompanying histologic lesions [8]. Cytotoxic and
genotoxic effects are also caused by TNT [9-11]. Our
recent toxicity studies in rats found that TNT decreased
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body weight, increased liver weight, and induced
erythrocytosis (Deng et al., unpublished data).
Although a variety of studies have focused on toxicity
aspects of TNT, the underlying mechanisms of toxicity
induced by this compound are largely unknown. Several
laboratories have started to use microarray analysis to
understand the molecular mechanisms of invertebrate
ecotoxicity. The exposure of the earthworm Eisenia
fetida with TNT regulates the expression of genes
involved in multiple biological processes including mus-
cle contraction, neuronal signaling and growth, ubiquiti-
nylation, fibrinolysis and coagulation, iron and calcium
homeostasis, oxygen transport, and immunity [12].
Microarray analysis of TNT exposed Arabidopsis thali-
ana (Arabidopsis) reveals the induced expression of
oxophytodienoate reductases (OPRs), the protein
responsible for TNT detoxification in Arabidopsis. The
same team also found that bifunctional O- and C-gluco-
syltransferases is involved in combating TNT induced
toxicity in Arabidopsis [2,13]. Eisentraeger et al. [14]
investigated the mechanism of human liver cell line
HepG2 treated with TNT using the toxicology cDNA
microarray. They found that the detoxification metabo-
lism in the HepG2 cells by TNT induced genes encoded
phase I and phase II enzymes.
In the current study, we examined gene transcriptional
responses to short term (24 h and 48 h) TNT exposures
in rat in both in vitro hepatocytes and in vivo liver. We
observed that a number of genes were commonly regu-
lated by both in vitro and in vivo TNT treatments. More-
over, we found commonly affected pathways in both in
vivo and in vitro systems exposed with TNT. Functional
analysis indicates that both TNT treatments in vivo and
in vitro impact genes involved in cell cycle, cell growth
and cell death signaling, detoxification response, lipid
metabolism and immune response, which can reasonably
account for the physiological dysfunctions induced by
TNT. In addition, we identified conserved gene networks
inferred from in vivo and in vitro networks. Our results
suggest that in vitro system can predict in vivo functions
and mechanisms based on gene expression profiles, and
gene network is a valuable approach for predicting in
vivo function using in vitro data.
Results
Commonly regulated genes by in vivo and in vitro TNT
treatments
To determine if in vitro TNT exposure could be used to
predict in vivo TNT exposure, the first aim of this
experiment was to determine if there were common
genes differentially regulated by both in vivo and in
vitro TNT treatments. For the in vivo experiment, rats
were gavaged with TNT at: 0 (control), 4.8, 48, 96 or
192 mg/kg and sacrificed after 24 h or 48 h. RNA was
isolated for microarray hybridization. Agilent rat whole
genome array (Agilent Technologies Inc., Palo Alto, CA)
was employed in the study. Four biological replicates
were used for each unique condition as described in the
Material and Methods. For the in vitro experiments, pri-
mary rat hepatocytes (Lonza, Walkersville, MD) were
cultured and treated with TNT at 10 ppm or vehicle
control for 24 h, after which RNA was isolated for
microarray experiments. The in vivo and in vitro micor-
array data have been deposited in the GEO databases
with assigned numbers GSE19628 and GSE19662,
respectively.
To identify genes differentially expressed in vivo, a
one-way ANOVA was applied to identify differentiated
transcripts across different doses of TNT treatments at
each of the 24 h or 48 h time points. A p value cut-off
of 0.05 and a 1.5 fold gene transcript change by compar-
ing at least one pair of conditions between different
doses including control were used as filters to identify
differentially expressed genes. A total of 4875 gene tran-
scripts were significantly and differentially expressed
(i.e., upregulated and downregulated) in in vivo TNT
treatment for all doses and time points.
An un-paired t-test with a p value cut-off of 0.05 and
1.5 fold change filter was used to test for differential
expression between controls and TNT treated hepato-
cytes in the in vitro assay yielding 967 differentially
expressed transcripts. A Venn diagram shows that there
were 341 transcripts that were commonly regulated by
both in vivo and in vitro TNT treatments (Figure 1 &
Additional file 1, Table S 1). The common differentiated
genes between in vivo and in vitro exposures suggest
that a common mechanism exists between in vitro TNT
and in vivo TNT treated liver systems.
Similar gene expression pattern shared by commonly
regulated in vivo and in vitro genes
We examined the expression pattern of the 341 common
transcripts from in vivo and in vitro TNT exposures. To
reach the goal, each sample was normalized by the mean
intensity of a gene of relative control samples, and the
samples under the same condition were averaged into
one condition. A two-way hierarchical clustering resulted
in two cluster dendrograms of the 341 transcripts across
10 in vivo conditions and 2 in vitro conditions (Figure 2).
The controls and 3 lower in vivo dose conditions (4.8, 48,
and 96 mg/kg) at 24 h were in a cluster, indicating that
these doses at 24 h are closer to controls and have less
genes affected than other conditions. The remaining in
vivo and in vitro TNT exposed hepatocytes and livers
formed the second cluster.
Overall, we found the conditons were more likely to
group together according to exposure duration than
dose concentration, implying that the time effect is
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stronger than the dose effect. Interestingly, we found
that 3 conditions (in vivo TNT treatment at 192 mg/kg
for 24 h, in vivo TNT treatment at 192 mg/kg for 48 h,
and in vitro TNT treatment for 24 h) fell into one sub-
group. Moreover, we noticed that the gene expression
patterns for the 192 mg/kg, 24 h in vivo TNT treatment
and the 24 h in vitro TNT treatment were similar. The
genes are upregulated (red pettern) by the in vitro treat-
ment, and they were usually upregulated in vivo treat-
ment. Most downregulated genes in in vitro were also
repressed in vivo. Since these two conditions behaved
closely, we directly compared commonly upregulated
and downregulated genes based on these two conditions.
Out of these 341 transcripts, 201 transcripts were upre-
gulated by the in vivo TNT treatment, and 214 tran-
scripts were upregulated by the in vitro TNT treatment.
One hundred sixty-four transcripts (77% of the in vitro
transcripts) were commonly upregulated under both
conditions (Figure 3A). One hundred forty in vivo TNT
transcripts and 127 in vitro TNT transcripts were down-
regulated. Furthermore, 90 transcripts (71% of the 127
in vitro transcripts) were reduced by both conditions
(Figure 3B). Another common phenomenon was that
both TNT exposed liver systems had more upregulated
than downregulated genes. Our results demonstrate that
TNT treatment in in vivo and in vitro liver systems
results in genes regulated in the same direction, provid-
ing more evidence that in vitro hepatocytes act as a sui-
table surrogate for in vivo liver exposures.
Functional analysis of commonly regulated genes
To understand the functions of the commonly regulated
genes, we identified most significantly functional cate-
gories using the Ingenuity function analysis tool (Inge-
nuity Systems, Inc., Redwood City, CA). These
functional groups mainly included cell cycle, carbohy-
drate metabolism, molecular transport, cell growth and
proliferation, cell death, DNA replication, recombination
and repair, lipid metabolism, cellular assembly and orga-
nization, and immune response (Table 1). The most sig-
nificant functional category regulated by TNT was cell
cycle, which possessed 31 genes, of which, 18 genes
were commonly downregulated by in vivo and in vitro
TNT exposures. The most heavily downregulated genes
involved in cell cycle by both in vivo and in vitro TNT
treatments included LGALS1, CYP26B1, and PTTG1.
Highly induced genes in this cell cycle category included
ADM, DUSP13, and PPARG. More genes participating
in cell cycle were downregulated, indicating that TNT
appears to interfere with cell cycle progress.
Other commonly significantly affected functional
terms were cell growth and proliferation (40 genes), cell
death (19 genes), DNA replication (19 genes), and
recombination and repair (19 genes). Interestingly, there
were 10 genes that were repeatedly present in all four
functional terms: ADM, CCNB1, CCND2, CXCL12,
LGALS, MYC, NRG1, NRG2, PPARG, and PTTG1. In
addition, these genes were consistently regulated by
both in vivo TNT and in vitro TNT in the same direc-
tions. The expression of CCNB1, CCND2, PTTG1,
CXC12, and LGALS1 was decreased by TNT, and the
expression of ADM, MYC, NGR1, NGR2, and PPARG
was elevated by TNT.
There were 23 commonly regulated genes that were
involved in molecular transport (Table 1). Nineteen of
the 23 genes (83%) were upregulated, and only 4 of
them were downregulated by both in vitro and in vivo
TNT treatments. Some significant upregulated genes
included NQO1, ADM, ABCC3 and ABCC4. Our results
suggest that TNT can enhance molecular transport both
in vivo and in vitro liver systems.
Twenty-three genes contributing to carbohydrate
metabolism were commonly regulated by both in vivo
and in vitro TNT treatments. Among them, only 6
genes were repressed and 17 genes were induced. The
expression of 27 genes participating in lipid metabolism
was significantly changed in response to both in vivo
and in vitro TNT exposures. Similar to carbohydrate
metabolism, we saw more upregulated genes (21) than
downregulated genes (6) in this category. Several
Figure 1 Commonly significantly regulated transcripts by TNT
in vitro and in vivo. For the in vivo experiment, rats were exposed
to TNT at various doses: 0 (control), 4.8, 48, 96 or 192 mg/kg for 24
h or 48 h. Subsequently rats were sacrificed and RNAs were isolated
for microarray hybridization using a Rat Agilent whole genome
array. For in vitro experiments, primary cultured rat liver cells were
treated with TNT at 10 mg/l or vehicle control, and RNAs were
isolated for microarray experiments using the same type of Agilent
array as the in vivo experiment. Differentiated transcripts were
analyzed as described in the Materials and Methods. The commonly
regulated transcripts are shown in the intersection part of the Venn
diagram.
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cytochrome P450 family members such as CYP1A1,
CYP3A43 and CYP2C18 were in the upregulated gene
list. Interestingly, 10 genes (MYC, PPARG, PPP1R3C,
CXCL12, GCK, ABCC3, ADM, CPT1A, H6PD, and
LGALS1) belong to the three functional categories:
molecular transport, carbohydrate metabolism and lipid
metabolism. Three of these 10 genes (LGALS1, GCK,
CXCL12) were downregulated and the other 7 genes
were upregulated by both in vivo and in vitro TNT
treatments.
There were 17 commonly regulated genes that were
involved in cellular assembly and organization. The
expression of 10 genes was decreased, while expression
of 7 genes were increased. Eight genes played a role in
immune response, 5 of which were downregulated and
3 genes upregulated. More immune response genes
Figure 2 Hierarchical clustering of experimental conditions. Experimental conditions were based on averaging samples with the same
treatments or controls of both in vitro and in vivo experiments. Total 12 experimental conditions including 10 in vivo and 2 in vitro were put
together for a Two-Way hierarchical clustering. 341 common transcripts (horizontal axis) were used for clustering across all the conditions
(vertical axis). A Pearson correlation algorithm was applied to calculate the distances between transcripts or between conditions. The relative
level of gene expression is indicated by the color scale at the right side.
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Figure 3 Comparison of upregulated and downregulated transcripts between in vivo and in vitro TNT treatments. Among 341
commonly regulated transcripts regulated by TNT in vitro and in vivo, commonly upregulated transcripts (A) and downregulated transcripts(B) of
these 341 transcripts between in vivo TNT treatment at 199 mg/ml for 24 h and in vitro TNT treatment are shown by the Venn diagram.
Table 1 Significant functional categories based on genes commonly regulated by TNT in vivo and in vitro
Category P-
value
Downregulated genes* Upregulated genes*
Cell Cycle 5.1E-
07-
1E-02
ANGPTL2, LGALS1, CYP26B1, COL1A1, CCND2, CKAP2,
CDKN3, KIF20A, CXCL12, ECT2, CCNB1, RARB, PTTG1, LZTS1,
TFDP2, BCL2A1, CDC2, INPP5D
MYC, CCNC, DNM1L, NRG2(includesEG:9542), MAPK1, NRG1,
TFRC, PPARG, CREG1, RIOK3, NTRK1, DUSP13, ADM
Carbohydrate
Metabolism
1.36E-
06-
1E-02
GCK, MMP2, INPP5 D, PTTG1, CXCL12, LGALS1 NQO1, ADM, PLA2G7, UGDH, GCLC, PPP1R3C, NTRK1,
PPARG, JMJD7, PLA2G4B, ABCC3, UGT1A6, CPT1A, PARD3,
NRG1, H6PD, SLC5A3, MYC
Molecular
Transport
1.36E-
06-
1E-02
GCK, PTTG1, CXCL12, LGALS1 MYC, SLC5A3, ABCG5, EIF2S1, GMFB, H6PD, MAPK1, NRG1,
PARD3, CPT1A, TFRC, ABCC3, PPARG, AQP8, ABCC4,
PPP1R3C, GCLC, ADM, NQO1
Cellular Growth
and Proliferation
1.25E-
05-
1E-02
LGALS1, COL1A1, CCND2, KIF20A, CXCL12, CCNB1, RARB,
PTTG1, LZTS1, HSD11B2, DLC1, COL1A2, BCL2A1, CDC2,
INPP5 D, MMP2
MYC, DNAJB6, NRG2 (includes EG:9542), CES2 (includes
EG:8824), MAFF, CDH4 (includesEG:1002), UGT2B17, MAPK1,
NRG1, TRIM35, TFRC, PPARG, CXCL2, ALDH1L1, CREG1,
GSTP1, HMGCR, NTRK1, CDA, PHLDA1, PFN2, GRIN2C, ADM,
CYP1A1
Cell Death 3.45E-
05-
1E-02
LGALS1, CYP26B1, CCND2, CKAP2, CXCL12, CCNB1, RARB,
PTTG1, HSD11B2, DLC1, BCL2A1, CDC2, INPP5 D, MMP2
MYC, DNAJB6, EIF2S1, DNM1L, NRG2(includes EG:9542),
GMFB, HTATIP2, MAPK1, NRG1, TRIM35, TFRC, EPHX1, PPARG,
CXCL2, SQSTM1, CYP2F1, GSTP1, GSR, NTRK1, ABCC4,
PHLDA1, GCLC, PLA2G7, TXNRD1, NR1I3, GRIN2C, ADM,
NQO1, NCF2
DNA Replication,
Recombination,
and Repair
1.52E-
04-
1E-02
LGALS1, CCND2, CXCL12, ECT2, CCNB1, PTTG1, MMP2 MYC, NRG2 (includes EG:9542), PDE5A, NRG1, PPARG, RIOK3,
GSTP1, GCLC, NR1I3, ADM, AMPD3, NQO1
Lipid Metabolism 2.6E-
04-
1E-02
GCK, INPP5 D, HSD11B2, CXCL12, PNPLA3, LGALS1 CYP1A1, ADM, PLA2G7, PPP1R3C, UGT2B7, NTRK1, ACOT4,
GSTP1, AQP8, PPARG, JMJD7-PLA2G4B, ABCC3, RDH16,
CPT1A, MAPK1, H6PD, UGT2B17, CYP3A43, CYP2C18, ABCG5,
MYC
Cellular Assembly
and Organization
5.88E-
04-
1E-02
LGALS1, COL1A1, ECT2, CCNB1, PTTG1, COL1A2, CDC2,
KRT20, INPP5D
MYC, DNAJB6, DNM1L, EPB41, NRG1, RIOK3, PFN2, ADM
Immune Cell
Trafficking
3.58E-
03-
1E-02
COL1A1, CYTIP, CXCL12 CXCL2
Humoral Immune
Response
5.57E-
03-
1E-02
CXCL12, BCL2A1, NPP5D MYC, NTRK1
* Full names of the genes are listed in Additional file 1, Table S 1.
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were downregulated, indicating that TNT may interfere
with normal immune function to induce its toxicity.
Overall, some commonly regulated genes were highly
represented. For instance, the gene MYC falls into all the
functional categories listed in Table 2. CXCL12 belongs
to all the functional groups except cellular assembly and
organization. ADM and LGALS1 genes PPARG were
absent in only two functional categories, cellular assem-
bly and organization, and immune response.
Pathway analysis
To further understand the gene function influenced by
TNT exposure to in vivo and in vitro liver cells, we con-
ducted a canonical pathway analysis using the Ingenuity
pathway analysis tool. Three separate gene lists were
used to run the pathway analysis: the list of genes most
significantly regulated by in vivo TNT treatment, the list
of genes most significantly regulated by in vitro TNT
exposure, and the list of the 341 commonly regulated
genes. In order to identify the most significantly influ-
enced pathways in vivo, a more stringent p value (p <
0.002) was applied, which resulted in 1106 significantly
regulated transcripts for the in vivo TNT experiment.
The top significantly impacted pathways from each gene
list are depicted in Figure 4. Using a threshold p value
of 0.05, a total of 47 pathways were regulated by in vivo
TNT treatment, 40 pathways were evidently affected by
in vitro TNT exposure, and 38 significantly pathways
were obtained by analyzing the common 341 genes
alone (Figure 5).
Twenty commonly regulated pathways were shared by
the in vivo and in vitro pathway lists, which is 50% of
the pathways impacted by in vitro TNT treatment
(Figure 5). The percentage of overlapping pathways was
much higher than that of overlapping genes illustrated
in Figure 1, indicating that the in vitro system perturbed
by TNT could reflect more biological truth for an
in vivo system from a mechanism related pathway view.
Sixteen consensus pathways were shared by the three
significant pathway lists (Figure 5 and Table 2). The top
regulated pathways with relative genes are listed in
Table 3. Several gene families that were highly repre-
sented in these pathways are related to xenobiotic meta-
bolism and transport. These families were cytochrome
P450 (CYP), glutathione S-transferase (GST), UDP glu-
curonosyltransferase (UGT), aldehyde dehydrogenase 1
(ALDH1) and ATP-binding cassette (ABC) families. The
regulated genes in the CYP family included CYPA1,
CYP2C18, CYP2F1, and CYP3A43. The genes listed in
Table 3 belonging to GST family included GST1 and
GSTA5. The UGT family included UGT1A6, UGT2B7,
and UGT2B17. The regulated gene aldehyde dehydro-
genase 1 family, member L1 (ALDH1L1) in the family
ALDH1 was involved in many pathways listed in
Table 3. The regulated genes in the ABC family
included ABCC3, ABCC4, and ABCG5.
Interestingly, all the genes in Table 3, except for
CCND2 and retinoid acid receptor beta (RARB), were
commonly upregulated by both in vivo and in vitro TNT
treatments. MAPK1, a critical intracellular signaling pro-
tein involved in multiple cellular functions (Table 1) was
also presented in multiple pathways such as NRF-2
mediated oxidative stress response, xenobiotic metabo-
lism signaling, and aryl hydrocarbon signaling pathways.
Inferring in vitro and in vivo gene networks
Motivated by commonly regulated genes, functional
terms and pathways, we then investigated whether a
Table 2 Commonly regulated canonical pathways based on in vivo, in vitro and common gene lists regulated by TNT
Pathway -Log(P-value) in vivo -Log(P-value) in vitro -Log(P-value) in vivo and in vitro
Metabolism of Xenobiotics by Cytochrome P450 7.26 4.77 5.82
NRF2-mediated Oxidative Stress Response 6.17 6.05 5.31
LPS/IL-1 Mediated Inhibition of RXR Function 5.66 6.29 3.48
Glutathione Metabolism 8.31 3.33 3.14
Xenobiotic Metabolism Signaling 5.05 5.14 4.4
Pentose and Glucuronate Interconversions 4.63 3.67 4.37
Aryl Hydrocarbon Receptor Signaling 3.82 3.84 3.93
PXR/RXR Activation 3.28 4.34 1.84
Pyruvate Metabolism 4.54 2.15 1.25
Galactose Metabolism 4.11 1.44 1.73
Fructose and Mannose Metabolism 4.19 1.33 1.65
Retinol Metabolism 1.98 1.97 2.59
Biosynthesis of Steroids 1.83 1.56 2.28
Fatty Acid Metabolism 2.3 1.87 1.48
Starch and Sucrose Metabolism 1.11 1.48 2.24
Androgen and Estrogen Metabolism 1.31 1.34 1.74
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common gene network was regulated by both the in
vitro and in vivo TNT treatments. To achieve this goal,
we used a reverse engineering algorithm called Context
Likelihood of Relatedness (CLR). CLR is based on
mutual information of any pair of genes and is a static
network. A static gene network reflects all possible
gene interactions for a given gene list. Therefore, the
more samples used to construct a gene network using
this algorithm make the built network more trust-
worthy. In order to build in vivo gene networks, 199
arrays from rat liver tissues treated with one of 5 com-
pounds TNT, 2-amino-4,6-dinitrotoluene (2A-DNT),
4-amino-2,6-dinitrotoulene (4A-DNT), 2,4-dinitroto-
luene (2,4-DNT) and 2,4-dinitrotoluene (2,6-DNT) or
vehicle controls were used (S. Meyer, unpublished
data). For in vitro gene network modeling, 531 arrays
resulted from liver primary cultured cells treated by
105 distinctive compounds with relative controls were
employed (D. Johnson, unpublished data). Using the
gene expression data of the commonly regulated 341
transcripts across the 199 arrays, an in vivo gene net-
work was constructed with the CLR algorithm. Figure
6A depicts the network which included 242 nodes and
417 edges. In vitro gene network was built using the
same 341 genes and the same CLR algorithm, but
expression data were generated from the 531 arrays.
The gene network from the in vitro data had 235
nodes and 352 edges (Figure 6B).
Figure 4 Top significantly canonical pathways based on in vivo, in vitro and common gene lists regulated by TNT. Three separate gene
lists resulted from most significantly regulated gene list in vivo(A), significantly regulated gene list in vitro(B) and commonly regulated gene list
between in vivo and in vitro (C) were used to run the pathway analysis. The bigger the -log(p-value) of a pathway is, the more significantly the
pathway is regulated. The threshold lines represent a p value with 0.05. Top 15 most significantly regulated pathways for each list are presented.
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Since transcriptional regulated gene networks are
trigged by transcription factors, we then counted the
connections of the transcription factors (TFs) in the 341
transcripts for the both in vivo and in vitro gene net-
works. Top TFs with most connections in the in vitro
gene network were cellular repressor of E1A-stimulated
genes 1 (CREG1), pirin (iron-binding nuclear protein)
(PIR), BTB (POZ) domain containing 11(BTBD11),
SAM pointed domain containing ets transcription factor
(SPDEF) and basic helix-loop-helix family, member e41
(BHLHE41). TFs with most connections in the in vivo
gene network included HIV-1 Tat interactive protein 2,
30kDa (HTATIP2), transcription factor Dp-2 (E2F
dimerization partner 2) (TFDP2), leucine zipper, puta-
tive tumor suppressor 1 (LZTS1), zinc finger protein
217 (ZNF217), PIR, and MYC. The transcription factors
that had over 15 connections in the both gene networks
included CREG1, PIR, BTBD11, LZTS1, ASB2, HES6,
and SQSTM1(Figure 6C). Two TFs, SPDEF and
BHLHE41, had at least twice more connections in the in
vitro gene network than that in the in vivo gene net-
work. Seven TFs including HTATIP2, MYC, NEQ1,
ZNF394, E2F3, DNAJB6 and TFDP2 possessed over
twice as many connections in the in vivo gene network
than that in the in vitro gene network.
Conserved in vitro and in vivo gene networks
By comparing the in vivo and in vitro gene networks
(Figure 6), we identified several conserved sub-networks
that were common in both gene networks (Figure 7).
The TF PTTG1 centered sub-gene network consisted of
7 genes (PTTG1, CCNB1, CDC2, CDKN3, CKAP2,
ECT2, and KIF20A), all of which are involved in cell
cycle processes. Moreover, all the genes in the cell cycle
Figure 5 Comparison of significantly canonical pathways based
on in vivo, in vitro and common gene lists regulated by TNT.
Three separate gene lists resulted from most significantly regulated
gene list in vivo, significantly regulated gene list in vitro and
commonly regulated gene list between in vivo and in vitro were
used to run the Ingenuity pathway analysis tool. The overlapped
significantly regulated pathways are presented in the Venn diagram.
A pathway enrichment p value less than 0.05 was considered as
significant.
Table 3 Top common pathways regulated by TNT in vitro and in vivo
Canonical Pathways Common regulated genes*
Metabolism of Xenobiotics by
Cytochrome P450
CYP3A43, CYP2F1, GSTP1, CYP1A1, CYP2C18, UGT1A6, UGT2B7, GSTA5, ALDH1L1, UGT2B17, EPHX1
NRF2-mediated Oxidative Stress
Response
GSR, AKR7A3, GSTP1, MAPK1, GSTA5, NQO1, GCLC, SQSTM1, DNAJB6, MAFF, TXNRD1, EPHX1
Xenobiotic Metabolism Signaling GSTP1, CYP1A1, UGT1A6, MAPK1, GSTA5, NQO1, ALDH1L1, GCLC, CES2 (includes EG:8824), UGT2B7, NR1I3,
UGT2B17, ABCC3
Aryl Hydrocarbon Receptor Signaling MYC, GSTP1, CYP1A1, CCND2, MAPK1, GSTA5, NQO1, RARB, ALDH1L1
Pentose and Glucuronate
Interconversions
TCAG7.1260, AKR7A3, UGDH, UGT1A6, UGT2B7, UGT2B17
LPS/IL-1 Mediated Inhibition of RXR
Function
GSTP1, ABCG5, CPT1A, GSTA5, NR1I3, ALDH1L1, CES2 (includes EG:8824), ABCC3, ABCC4
Glutathione Metabolism GSR, GSTP1, GSTA5, H6PD, GCLC
PXR/RXR Activation CPT1A, NR1I3, CES2 (includes EG:8824), ABCC3
* Full names of the genes are listed in Additional file 1, Table S 1.
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sub-network were consistently repressed by both in vivo
and in vitro TNT treatments. The conserved sub-net-
work provides further evidence that the cell cycle pro-
cess may be impaired in both in vivo and in vitro
systems treated with TNT.
The TFs PIR, BTBD11, HTATIP2, and CREG1 were
colocalized in the biggest conserved sub-network
(herein called the PBHC network). Eight genes were
connected with the TF PIR centered sub-gene network
module (Figure 7), and contained highly enriched genes
associated with oxidoreductase activity (ACOT4,
AKR7A3, RDH16, TXNRD1, and UGDH). AKR7A3 and
TXNRD1 also participate in NRF2-mediated oxidative
stress pathway. All the genes in this network module
were upregulated by both in vivo and in vitro TNT
exposures. This result suggests that oxidative stress is
activated by TNT [15].
The TF CREG1 centered sub-network module
included 5 genes (Figure 7), 3 of which were also cell
cycle related genes (CREG1, NTRK1 and DUSP13). In
contrast to PTTG1 centered sub-network, all the genes
in the CREG sub-network module were upregulated by
both in vivo and in vitro TNT treatments. Glutathione
reductase (GSR), a gene related to oxidoreductase activ-
ity, and TXNRD1 provided the connections between the
CREG1, HTATIP2, and PIR sub-networks (Figure 7),
creating a larger 13 gene sub-network. In addition, GSR
also participated in the NRF2-mediated oxidative stress
pathway. Indeed, we found that all the genes in the big-
gest conserved sub-network formed by CREG1, HTA-
TIP2, BTBD11, and PIR mediated modules were
consistently upregulated by both in vivo and in vitro
TNT additions.
Verification of microarray responses using real time QRT-
PCR
To verify the credibility of microarray and gene network
modeling results, we selected 13 genes to perform real
time quantitative PCR (QRT-PCR) both in vitro and in
vivo. The genes chosen consistently played key roles in
functional categories and pathways altered by TNT
exposures in vivo and in vivo. As illustrated in Figure 8,
Figure 6 In vivo and in vitro transcriptional gene network views. Both gene networks were built using common genes regulated by TNT in
vivo and in vitro. The in vivo gene network (A) was constructed using 200 arrays from rat liver tissues treated with one of 5 compounds TNT,
2,4-DNT, 2,6-DNT, 2A-DNT and 4A-DNT or vehicle controls. The in vitro gene network (B) was modeled using 531 arrays resulted from liver
primary cultured cells treated by one of 105 compounds with relative controls. The Context Likelihood of Relatedness (CLR) algorithm was
employed to build both gene networks. Yellow highlighted genes are transcription factors. (C) Number of connections of transcription factors in
vivo and in vitro gene networks. The number of connections of transcription factors in vivo and in vitro gene networks exhibited in Fig. 6A, B was
counted.
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we observed good consistency between microarray and
QRT-PCR results. Similar upregulation and downregula-
tion trends were seen with both microarray data and
QRT-PCR data for all 13 genes. The overall regression
coefficient of the two methods across various conditions
was 0.875 (Figure 8C). Our results indicate the microar-
ray data quality is good and our interpretation and ana-
lysis should be convincing. Specific comparisons
between microarray and QRT-PCR are presented in
Additional file 2, Figures S 1A-1F.
For instance, the gene ABCC3 was shown in microar-
ray (Additional file 2, Figure S 1A) to be upregulated at
both 24 h and 48 h with a clear dose response to in vivo
TNT treatment, and was also induced by TNT in vitro,
and the same pattern was exhibited by QRT-PCR (Addi-
tional file 2, Supplementary Figure 1A). In both micro-
array and QRT-PCR results, the gene AKR7A3 was
upregulated at both time points in vivo as well as upre-
gulated in vitro. Interestingly, AKR7A3 was significantly
upregulated at the highest dose (192 mg/kg) in vivo at
48 h but not at other lower doses, which was shown
consistently by both microarray and QRT-PCR (Addi-
tional file 2: Figure S1 A). For the gene CYP1A1, we
saw it was upregulated more in response to in vitro
TNT than in vivo TNT treatment, and was induced
much more at 24 h than 48 h in vivo, which was consis-
tently revealed by both microarray and QRT-PCR
results (Additional file 2, Figure S 1C). Three genes
PTTG1 (Figure 8), CCNB1 and CCND2 that were in
PTTG1 centered subnetwork were consistently shown
to be downregulated by TNT in vivo and in vitro, with
both approaches (Additional file 2, Figures S 1B and F).
The QRT-PCR results could exactly confirm our two
observations obtained from the microarray data: the
genes up or downregulated in the same directions in
vitro and in vivo, and a clear dose response in vivo.
Discussion
In this study, we compared gene expression profiles
regulated by TNT exposure in vivo and in vitro from
shared gene lists, functional terms, common pathways,
and conserved networks. Overall, good consistency
existed between in vitro and in vivo exposures. The
Venn diagram (Figure 1) shows that a only small per-
centage of the in vivo transcripts were also regulated in
the in vitro experiments. Because the regulated gene
number in vivo is the total number from all TNT treat-
ments including multiple doses and two time points (24
h and 48h), the gene number is much larger than that
of in vitro exposures. However, the in vitro gene number
comes from only one dose. The reason we used one
dose is that the in vitro experiment is a large one with a
total of over 105 chemicals and 531 arrays. But if we
compare the overlapped transcripts with the in vitro
transcripts (940), the number of overlapped transcripts
is not small, with over one third of the total in vitro
Figure 7 Conserved sub gene networks between in vitro and in vivo gene networks. By comparing in vivo and in vitro gene networks
(shown in Fig. 6), conserved subnetworks that had the same connections in the both networks were achieved. Transcription factors are
highlighted as yellow.
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transcripts. This observation is found more than in
overlaps examined in other publications ([16]. Also we
would like to emphasize that the gene expression pat-
terns for the 192 mg/kg, 24 h in vivo TNT treatment
and the 24 h in vitro TNT treatment are similar. If we
only count the regulated transcript number for
192 mg/kg, 24 h in vivo TNT treatment (Figure 2), the
number is comparable to that of the 24 h in vitro TNT
treatment. In addition, in vivo and in vitro are two dif-
ferent systems, we cannot expect that they are exactly
the same. Our purpose is to identify common tran-
scripts between these two systems, thereby to under-
stand the in vivo function through the in vitro system.
From the perspective of functional analysis, both TNT
treatments in vivo and in vitro influence genes involved
in cell cycle, cell growth and cell death signaling, detoxi-
fication response, lipid metabolism and immune
reponse, which can reasonably explain the physiological
dysfunctions induced by TNT. We also found conserved
sub-networks between inferred networks from in vivo
and in vitro TNT regulated gene expression profiles.
Cell cycle, cell growth, and cell death signaling
A large number of genes involved in cell cycle, cell
growth and cell death were commonly regulated in both
in vitro and in vivo systems perturbed by TNT. The
highly represented downregulated genes were CCNB1,
CCND2, PTTG1, CXC12, and LGALS1, and the highly
represented upregulated genes were ADM, MYC, NRG1,
NRG2, and PPARG. The cyclin B1 (CCNB1) gene
product complexes with p34(cdc2) to form the matura-
tion-promoting factor (MPF). CCNB1 is expressed pre-
dominantly during G2/M phase because of its critical
role in cell mitosis [17,18]. The protein encoded by
CCND2 belongs to the highly conserved cyclin family,
whose members are characterized by a dramatic periodi-
city in protein abundance through the cell cycle. Cyclins
function as regulators of CDK kinases. Different cyclins
exhibit distinct expression and degradation patterns
which contribute to the temporal coordination of each
mitotic event. The CCND2-translated cyclin forms a
complex with and functions as a regulatory subunit of
CDK4 or CDK6, whose activity is essential for cell cycle
G1/S transition. PTTG1 encoded protein is a homolog
of yeast securin proteins, which prevent separins from
promoting sister chromatid separation. The gene pro-
duct contains 2 PXXP motifs, which are essential for its
transforming and tumorigenic activities, as well as for
its stimulation of basic fibroblast growth factor expres-
sion [19-21]. Besides the functions of cell cycle and
growth, the major role of CXC12 is involved in immune
response. The protein encoded by LGALS1 is a member
of beta-galactoside-binding protein family implicated in
modulating cell-cell and cell-matrix interactions, which
may act as an autocrine negative growth factor that reg-
ulates cell proliferation [22].
The protein product of the gene Adrenomedullin
(ADM) is a multifunctional peptide vasodilator that car-
ries out its functions through calcitonin receptor-like
Figure 8 Quantitative real-time RT-PCR (QRT-PCR) verification
of microarray gene expression. Both QRT-PCR (A) and microarray
(B) results of the gene PTTG1(G) were presented. The experimental
design was the same as the microarray experiment. The expression
value for a given gene was represented as a log2 ratio of ratio of
exposed versus respective control RNA. The correlation of total 13
genes across different conditions (n = 156) between the microarray
and RT-PCR data was shown on Fig. 8C. Bars represent the standard
errors for the average log2 ratios of biological replicates.
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receptor/receptor activity modifying protein-2 and -3
(CLR/RAMP2 and CLR/RAMP3). It can positively
enhance cell proliferation [21]. MYC is a well known
multifunctional, nuclear phosphoprotein that contributes
to cell cycle progression, apoptosis and cellular transfor-
mation [23]. It acts as a transcription factor that regu-
lates transcription of specific target genes. It has been
implicated as an oncogene to facilitate cell growth and
survival. The protein encoded by NRG1 was initially
characterized as a 44-kD glycoprotein that interacts with
the NEU/ERBB2 receptor tyrosine kinase to increase its
phosphorylation on tyrosine residues. This protein is a
signaling protein that regulates cell-cell interactions and
is involved in the promotion of growth and development
of multiple organ systems [24,25]. Neuregulin 2 (NRG2)
is a new member of the neuregulin family of growth
and differentiation factors. By interacting with the Erbb
family of receptors, NRG2 induces the growth and dif-
ferentiation of epithelial, neuronal, glial, and other cell
types [26]. The gene PPARG encodes a member of the
peroxisome proliferator-activated receptor (PPAR) sub-
family of nuclear receptors. PPARs form heterodimers
with retinoid X receptors (RXRs) and these heterodi-
mers regulate transcription of various genes to execute
various functions including lipid metabolism and cell
growth [27,28].
The gene BCL2A1, encodes a member of the BCL-2
protein family, a well known protein family functioning
as anti- and pro-apoptotic regulators[29]. The protein
encoded by this BCL2A1 is able to reduce the release of
pro-apoptotic cytochrome c from mitochondria and
block caspase activation, thereby enhance cell survival.
The reduction of the expression of this gene could par-
tially account for the cell damage induced by TNT.
Interestingly, the downregulated genes involved in cell
growth and cell death also play a role in the cell cycle
process. Therefore, the cell growth and other possible
cell death related phenotypes may occur primarily
through interrupting cell cycle progression of cells.
Recently we found that there was weight loss in rats
treated with TNT (data not shown). The possible reason
for the body weight loss is that cell growth is reduced
by TNT. TNT could inhibit the growth of V79 and TK6
human lymphoblastic cells [30]. It could explain cyto-
toxic effects caused by TNT [9-11].
Detoxification response
Our results revealed a couple of pathways that were
commonly regulated by both in vivo and in vitro TNT
treatments. From the pathways listed in Table 3, we
identified xenobiotic metabolism signaling as the key of
all the pathways because all the other pathways are
involved in xenobiotic metabolism signaling. Certainly,
several phase I and II metabolizing enzymes with their
family members that take part in multiple pathways play
a pivotal role in the detoxification process. These
enzymes mainly cover CYPs, GSTs, UGTs, AKR7A3,
ALDHL1, NQO1, and EPHX1. As expected, all these
enzymes were consistently elevated by both in vitro and
in vivo TNT treatments.
CYP1A1 has been a hallmark for the treatments of
many toxins and carcinogens [31-34]. CYP1A1 was
strongly induced in both in vivo and in vitro liver cells
by TNT. Due to its catalytic function, it could play dual
roles in the cells in the presence of TNT. Its activation
leads to the production of reactive oxygen species (ROS)
[35] which induces oxidative stress, lipid peroxidation
(LPO), protein modification and denaturation, and DNA
damage, and thus induces toxicity. Meanwhile, it may
also directly metabolize TNT or its metabolites, result-
ing in cell survival. Glutathione transferases (GSTs) cat-
alyze the conjunction of reduced glutathione (GSH) to
electrophiles and oxidative stress products, thus facilitat-
ing their removal [36].
UGTs catalyze the generation of glucuronide conju-
gates of dihydrodiols to execute their detoxification
function [37]. AKR7A3 catalyzes aflatoxin B1 (AFB 1)
and suppresses AFB1 dialdehyde metabolite to its corre-
sponding mono and dialcohols. Hence, the activation of
AKR7A3 attenuates the toxicity of the AFB1-dialdehyde
that reacts with proteins, and thus decreases AFB1-
induced toxicity [38].
ALDH1L1 is well recognized as protectors against
ROS caused oxidative damage. It metabolizes reactive
products of toxic LPO, which include 4-hydroxy-2-
nonenal (4-HNE) and malondialdehyde (MDA) [39].
This protective mechanism could explain how ALDH
responds to the cellular recovery to TNT exposure.
As a cytosolic flavoenzyme, NQO1 catalyzes the two-
electron reduction of diversified substrates [40]. NQO1
is characterized as a detoxification enzyme mainly
because of its capability of degenerating quinone sub-
strates to their less toxic hydroquinone metabolites,
bypassing the redox-cycling semiquinone radical [41,42].
NQO1 can also transform ubiquinone and vitamin E
quinone to their antioxidant forms [42].
EPHX1 is one member of epoxide hydrolases (EPHs)
that catalyze the hydrolysis of electrophiles such as
epoxides to the less reactive vicinal diols, which can
explain the mechanism of epoxide hydrolases as classi-
cal detoxifying enzymes. EPH is able to inactivate
highly diversified reactive epoxides with different struc-
tures, and therefore plays a critical role in the enzy-
matic defense against adverse effects of xenobiotic
compounds [43].
Many upregulated genes involved in xenobiotic meta-
bolism signaling also participate in cell cycle, cell
growth, and cell death. Our results suggest that, upon
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exposure to TNT, cells arrest the cell cycle and increase
detoxification and oxidative stress enzymes to remove
the xenobiotic and eliminate any cell damage caused by
the xenobiotic..
Lipid metabolism
Several genes participating in lipid metabolism were
commonly regulated by both in vivo and in vitro TNT
exposures. Most of these lipid metabolism genes showed
elevated expression, while only a small number of genes
were repressed. The downregulated genes included
LGALS1, PNPLA3, CXCL12, HSD11B2 and INPP5 D.
One well known gene, inositol polyphosphate-5-phos-
phatase, 145kDa (INPP5 D, or SHIP-1), encodes a protein
that is largely confined to hematopoietic cells. It is a well
characterized inhibitory molecule that is recruited by
engagement of the inhibitory Fcg type IIB receptor in B
cells and mast cells or by engagement of Fcε type I or Fcg
type III, cytokine, and growth factor receptors in myeloid
cells [44]. Once recruited to the plasma membrane by
signaling complexes, its enzymatic activity depletes
PtdIns(3,4,5)P3 and prevents membrane localization of
some PH domain-containing effectors, eventually leading
to impaired PI3K-dependent signaling events.
The protein encoded by the gene PNPLA3 is a member
of the adiponutrin family complement the hormone sensi-
tive lipase (HSL) as responsible for adipocyte triacylgly-
cerol lipase activity. Mice lacking HSL reveal a lean
phenotype and accumulate diglycerides suggesting that
HSL is the main enzyme for the second step of lipolysis
[45]. LGALS1 has been shown to be involved in many
other functions in Table 1, also plays a role in lipid
metabolism, by increasing the induction of levels of phos-
phatidylserine as well as the mobilization of phosphatidyl-
serine [46]. Hydroxysteroid (11-beta) dehydrogenase 2
(HSD11B2) has been reported to contribute to the meta-
bolism of aldosterone, cortisone, glucorticoid and hydro-
cortisone [47,48]. The downregulated genes involved in
lipid metabolism may indicate that TNT may interrupt
lipid metabolism to some degree. The lipid metabolism
was also impaired in the liver of quail exposed to 2,6-DNT
[49]. Meanwhile, we saw many other genes involved in
lipid metabolism upregulated by TNT, many of which
overlap with xenobiotic signaling genes (Table 3), suggest-
ing that they also function for detoxification by trying to
recover normal lipid metabolism.
Immune response
As described earlier in the results, 5 of 8 genes asso-
ciated with immune response were downregulated by
TNT both in vivo and in vitro. These 5 genes are
CXCL12, COL1A1, BCL2A1, INPP5 D, and CYTIP.
Chemokine (C-X-C motif) ligand 12 (CXCL12 or
SDF-1) was strongly downregulated by TNT. It is a
ligand for the G-coupled receptor protein chemokine
(C-X-C motif) receptor CXCR4. Activation of CXCR4
by CXCL12 is involved in many biological functions
such as cell migration, growth, and survival [50].
Besides enhancing cell survival, BCL2A1 is a direct tran-
scription target of NF-B in response to inflammatory
mediators, and is upregulated by different extracellular sig-
nals such as granulocyte-macrophage colony-stimulating
factor (GM-CSF), CD40, phorbol ester and inflammatory
cytokines TNF and IL-1, which suggests a cytoprotective
function that is essential for lymphocyte activation, and
plays a role in immune response [51].
COL1A1 encodes the pro-alpha 1 chains of type I col-
lagen whose triple helix is composed of two alpha 1
chains and one alpha 2 chain. Type I collagen is a fibril-
forming collagen found in most connective tissues and
is abundant in bone, cornea, dermis and tendon. Thus
this gene is critical for cell aggregation, migration, pro-
liferation, binding, adhesion and growth [52]. This gene
carries out its immune response by primarily affecting
transmigration of T lymphocytes. As a gene primarily
functioning in lipid metabolism, INPP5 D participating
in immune response by mainly maintaining the quantity
of B lymphocytes and participating in phospholipid
metabolism [53]. Cytohesin 1 interacting protein
(CYTIP) encodes a protein containing 2 leucine zipper
domains and a putative C-terminal nuclear targeting sig-
nal. Its major role is involved in the quantity mainte-
nance, migration of leukocytes and lymphocytes [54].
The decreased above gene expression could explain
the interference of normal immune response by TNT
both in vitro and in vivo, which could lead to inflamma-
tion and other immune related toxicities caused by
TNT.
Network as a valuable approach for predicting in vivo
function using in vitro data
Finally, not only could we find commonly regulated
genes, functional terms, and pathways, but we were also
able to identify conserved gene networks between in
vitro and in vivo liver systems perturbed by TNT. There
were two big conserved sub-networks, the TF PTTG1
centered gene network and the TFs PIR, BTBD11,
HTATIP2 and CREG1-connected gene network (PBHC
network). Interestingly, all the genes in the PTTG1 sub-
network were associated with cell cycle function. For
example, CDC2 and cyclin B (CCNB1) form a complex
which is responsible for the onset of metaphase [55].
PTTG1, CDC2, and CCNB1 all participated in the mito-
tic roles of Polo-Like kinase pathway [56,57]. Further-
more, all the genes in the PTTG sub-network were
downregulated by TNT in vitro and in vivo. Since cell
cycle is the most significant functional term affected by
TNT both in vitro and in vivo (Table 1), this conserved
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cell cycle relating network could well explain the com-
mon mechanism of TNT treated liver systems both in
vivo and in vitro, which is that cell cycle progression is
interfered by TNT, thereby leading to cell growth inhi-
bition and cell death, ultimately cause toxicity [58-60].
We did observe liver cell death in rats exposed to high
dose TNT (Deng et al., unpublished data).
In the PBHC sub-network, some genes such as
CREG1, NTRK1, DUSP13, GSR, and TXNRD1 play a
role in cell cycle and/or cell death. Many genes possess
oxidoreductase activity [61], and are involved in oxida-
tive stress process and play a crucial role in metaboliz-
ing toxic compounds and their metabolites. The TF PIR
encodes a TF which is a member of the cupin superfam-
ily. The encoded protein is a Fe(II)-containing nuclear
protein expressed in all tissues of the body and concen-
trated within dot-like subnuclear structures [62]. Inter-
actions with nuclear factor I/CCAAT box transcription
factor as well as B cell lymphoma 3-encoded oncopro-
tein suggest the encoded protein may function as a tran-
scriptional cofactor and be involved in the regulation of
DNA transcription and replication. Interestingly, the TF
HTATIP2 also has oxidoreductase activity [63], and
connects two genes GSR and TXNRD1 that both pos-
sess oxidoreductase activity as well as both take part in
NRF2-mediated oxidative stress pathway. HTATIP was
reported to be regulated by NRF2, too [64].
Overall, we can see that the genes in the PBHC sub-
network are involved in cell cycle growth, and/or oxi-
doreductase activity. Surprisingly, 17 genes in the PBHC
sub-network (Figure 7) were all consistently upregulated
by TNT both in vivo and in vitro. The induction of
these gene expression lead to cell survival and removal
of toxic products, therefore, this conserved sub-network
may well explain the common detoxification mechanism
both in vivo and in vitro liver systems treated with TNT.
We did not use only TNT-exposed samples but
included all samples in the pool to construct static gene
networks, which aim to uncover any gene interactions.
In so doing, the more samples and conditions included
make the network analyses more robust. For instance,
Faith et al. (2007) used 445 arrays with over 180 various
conditions to build an E. Coli static gene network.
Because the genes we used are TNT-regulated genes,
the constructed gene networks are specifically TNT-
regulated networks.
We built separate gene networks using in vitro and in
vivo samples and found commonly conserved networks.
These common networks are ideal because they validate
both in vivo and in vitro conditions.
Conclusions
Our results indicate that TNT perturbed similar gene
regulated networks when in vitro effects on hepatocyte
cells are compared with in vitro effects on liver. Thus,
gene regulatory networks obtained from an in vitro sys-
tem can be predictive of in vivo function in the liver
when perturbed by a chemical stressor such as TNT.
Furthermore, PTTG1 regulated cell cycle may be a key
targeted process indicator for TNT induced toxicity.
This study is the first report to use an in vitro tran-
scriptional regulatory gene network to predict in vivo
toxicity and mechanism induced by a chemical. Knowl-
edge achieved from this innovative study can provide an
efficient way to assess whether a soldier or civilian has
been exposed to TNT and to find possible ways to pre-
vent, treat, and reduce TNT induced adverse effects.
Methods
Microarray experimental design
Changes in gene expression were tested using Agilent
commercial whole rat genome microarrays (4 X 44K).
For in vivo experiment, one of five compounds (2,4-
DNT, 2,6-DNT, TNT, 2-ADNT and 4-ADNT) were
used to treat rats. Female Sprague-Dawley rats (175-225
grams) were from the in-house breeding colony (College
of Pharmacy, University of Louisiana at Monroe [ULM]
and treated in accordance with the Guide for Use and
Care of Animals [65]. Breeders were from Harlan-Spra-
gue Dawley in Madison, WI. Housing consisted of a 12
h light/dark cycle with ad libitum access to tap water
and rodent chow (Harlan/Teklad 7012, Madison, WI).
Rats were housed individually in polycarbonate cages on
hardwood bedding (Sani-chips, Harlan/Tekland, Madi-
son, WI) one week prior to treatment. Food was with-
drawn the night before treatments, which were
administered by gavage between 8 and 10 AM. Study
protocols were preapproved by the ULM Animal Care
and Use Committee.
Groups of rats were weighed and randomly assigned
to treatment. Treatments were vehicle (5% v/v DMSO
in corn oil), 2,4-DNT (4.8, 48, 96, and 192 mg/kg), 2A-
DNT (4.4, 44, 87 and 174 mg/kg) and 4A-DNT (4.7, 47,
94 and 187 mg/kg), TNT (4.8, 48, 96 and 192 mg/kg),
and 2,6-DNT (5.0, 25, 50 and 99 mg/kg). Rats were
observed continuously for the first hour after dosing,
hourly for 8 h and daily thereafter. Moribund rats were
euthanized with CO2. Livers were excised and weighed.
A portion of the liver was removed and placed in RNA
Later (Ambion) following manufacturer’s instruction
and later used for genomic analyses. Remaining liver
was flash frozen in liquid N2 and stored at -70°C for
further analyses.
For in vitro experiment, primary cultured rat hepato-
cytes (Lonza, Walkersville, MD) were kept in an incu-
bator at 37°C and 5% CO2. After seeding in flasks
(3x106 cells/flask), the cells were treated with 10 mg/l
TNT and vehicle control (DMSO). Three experimental
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replicates were used. After 24 h, the cells were isolated
and lysed for RNA analysis. Cells were also treated
with one of 106 compounds, including TNT (10 mg/l),
and relative controls. At least three biological replicates
were used for each unique condition (Additional file 3,
Table S 3).
Total RNA extraction
Total RNA was extracted from about 30 mg of liver tis-
sue or cell pellet. Tissues or cells were homogenized in
the lysis buffer with FAST Prep-24 from MP at speed
6.0/s twice, each last 30 s before using RNeasy kits (Qia-
gen). Total RNA concentrations were measured using
NanoDrop® ND-1000 Spectrophotometer (NanoDrop
technologies, Wilmington, DE, USA). The integrity and
quality of total RNA was checked on an Agilent 2100
Bioanalyzer (Palo Alto, CA). The gel-like images gener-
ated by the Bioanalyzer show that total RNAs have two
bands, represent 18 S and 26 S RNA of mammalian
RNA. Nuclease-free water (Ambion) was used to elute
total RNA.
Microarray hybridization
Rat whole genome oligo arrays in the format of 4X44K
were purchased from Agilent. Sample cRNA synthesis,
labeling, hybridization and microarray processing were
performed according to manufacturer’s protocol “One-
Color Microarray-Based Gene Expression Analysis”
(version 1.0). The Agilent One-Color Spike-Mix (part
number 5188-5282) was diluted 5000-fold and 5 μl of
the diluted spike-in mix was added to 1000 ng of each
of the total RNA samples prior to labeling reactions.
The labeling reactions were performed using the Agi-
lent Low RNA Input Linear Amplification Kit in the
presence of cyanine 3-CTP. The labeled cRNA from
each labeling reaction was hybridized to individual
arrays at 65°C for 17 h using the Agilent Gene Expres-
sion Hybridization Kit. After washing, the arrays were
scanned at PMT levels 350 using GenePix 4200AL
scanner (Molecular Device Inc.), the Feature extrac-
tion software (V. 9.5.1) from Agilent was used to auto-
matically find and place microarray grids, reject outlier
pixels, accurately determine feature intensities and
ratios, flag outlier pixels, and calculate statistical
confidences.
Microarray data analysis
Microarray data analyses were processed with Gene-
Spring version 7.0 and 10.0. The sample quality control
was based on the Pearson correlation of a sample with
other samples in the whole experiment. If the average
Pearson correlation with other samples was less than
80%, the sample was excluded for further analysis. If the
scanned intensity was less than 5.0 for a probe, it was
transformed to 5. A perchip (within) array normalization
was performed using 50 percentile values of all the
probe values in the array. Per gene (between) array nor-
malization was also applied using the median value of a
gene across all samples in the experiment. Probe fea-
tures were first filtered using flags. A “present” or
“absent” flag was defined using the Agilent Feature
Extraction 9.5.1 software. Only a probe that had present
flags in at least 50% samples of all the arrays was kept
for further analyses. Data were subsequently log (base 2)
transformed for statistical analyses.
To identify differentiated genes that responded to
TNT treatment with various doses in vivo, One-Way
ANOVA was performed across 5 doses at each time
point (24 h or 48h). A cut off p value 0.05 was used
to find statistically changed genes, and a 1.5 fold
change showing at least one pair of doses at each time
point was further applied to filter less significantly
regulated genes. To idenitfy differential genes after
TNT treatment in vitro, an un-paired t-test with cut
off p value 0.05 was applied to compare control sam-
ples and TNT exposed samples. In additon, 1.5 fold
change was applied to identify more signifcantly regu-
lated genes.
Gene functional analysis and pathway analysis
Significantly regulated probes were employed for
two-way hierarchical clustering (clustering both genes
and samples) using GeneSpring 7.0. A Pearson correla-
tion with average linkage was applied for the clustering.
Gene functional categories were classified according to
the Ingenuity knowledge base tool. A Gene functional
term enrichment p value less than 0.05 was considered
significant. Pathway analysis was performed using the
Ingenuity canonical pathways analysis tool. Similar to
functional term analysis, a pathway with an enrichment
p value less than 0.05 was considered to be a signifi-
cantly regulated pathway.
Reverse-transcription quantitative PCR (QRT-PCR)
Two-stage RT-QPCR were performed, 1000 ng of total
RNA were first reverse transcribed into cDNA in a
20 μl reaction containing 250 ng random primers and
SuperScript™ III reverse transcriptase (Invitrogen)
following the manufacturer’s instruction. The synthe-
sized cDNA was diluted to 10 ng/μl as cDNA template.
QPCR was performed on ABI Sequence Detector 7900.
Each 20-μl reaction was run in duplicate and contained
6 μl (10ng/μl) of synthesized cDNA templates and 3 μl
of nuclease-free water along with 1 μl of TaqMan gene
specific assay and 10ul of 2× TaqMan universal PCR
Master Mix (ABI). Cycling parameters were 95°C for 15
min to activate the DNA polymerase, then 40 cycles of
95°C for 15 s and 60°C for 1 min.
Deng et al. BMC Systems Biology 2010, 4:153
http://www.biomedcentral.com/1752-0509/4/153
Page 15 of 18
Inferring gene networks using a reverse engineering
algorithm
Gene networks were inferred using one of information-
theoric network algorithm called Context Likelihood of
Relatedness (CLR), which has been demonstrated to
outperform other algorithms [66]. CLR computes a
mutual information (MI) score between any pair of
genes. The significance of a MI score was determined
by comparing the MI score to a background distribution
of MI values. This background distribution was achieved
for each pair of genes with their MI scores with all
other genes in the list. The CLR value between genes A
and B was calculated by the formula:
Az Bz2 2+
Az and Bz are the z-score based on of A’s and B’s MI
score distribution respectively between gene A and gene
B [67]. Ten bins were used for the binning parameters
of CLR, with a spline degree of 3. A cut-off z-score was
set to 2.0 so that only the most significant interaction
edges could be counted. Networks were visualized by
Cytoscape [68,69].
Additional material
Additional file 1: Table S1. A table (supplementary table 1) providing a
list of transcripts that were commonly regulated by TNT in vivo and in
vitro.
Additional file 2: Table S2 and Figure S1. A PDF including
supplementary materials and methods, supplementary table 2 and
supplementary Figure 1.
Additional file 3: Table S3. A table (supplementary table 3) shows in
vitro experimental design.
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